Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - OTHER LONG-TERM ASSETS
Other Long-term Assets EBS - Emergent BioSolutions Inc.
178 M
LAST VALUE
76.30%
2 YEAR CAGR
67.03%
5 YEAR CAGR
48.68%
10 YEAR CAGR